LSBio
PathPlus™ CANX / Calnexin Antibody (C-Terminus)

Human Kidney: Formalin-Fixed, Paraffin-Embedded (FFPE)

PathPlus™ CANX / Calnexin Antibody (C-Terminus)

Primary AntibodyLSBio Guarantee
Antibody:Goat Polyclonal
Applications:Immunofluorescence, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Dog, Human, Mouse, Non-Human Primate, Rat
Format:Liquid
See all CANX / Calnexin antibodies →
$470.00each
Catalog Number: LS-B12410-200

For bulk orders or custom formulations:

Request a Quote

Overview

Description
Calnexin antibody LS-B12410 is an unconjugated goat polyclonal antibody to Calnexin (CANX) (C-Terminus) from human. It is reactive with human, mouse, rat and other species. Validated for IF, IHC and WB. Cited in 1 publication.
Application
IF, IHC, IHC-P, WB
Reactivity
Can, Hu, Ms, NHP, Rt
Intended Use
Research Use Only
Guarantees
This product carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Polyclonal Antibodies
Alternative Names
CANX | CNX | Calnexin | IP90 | p90
Recommended Dilution: IF/ICC
1:50 - 1:500
Recommended Dilution: IHC-P
5 µg/ml
Recommended Dilution: WB
1:500 - 1:2000
UniProt Number
P27824
SwissProt
P27824

Target

Target
CANX / Calnexin
Antigen Species
Human
Epitope
Detects a band of 90 kDa by Western blot in the following human (293A, primary fibroblasts, HaCat, HeLa, HMEC-1, Jurkat, MNT1, U-118), rat (TR-iBRB), mouse (3T3, AtT-20, Hepa, Raw264.7), monkey (COS-7) and canine (D17) whole cell lysates.
Gene Name
CANX

Antibody

Host Species
Goat
Clonality
Polyclonal
Origin Species
Human

Immunogen

Immunogen
Purified recombinant peptide within residues 550 aa to the C-Terminus of human CANX produced in E. coli.

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, 0.05% Sodium Azide, 20% Glycerol
Concentration
2 mg/mL
Animal Free
No
Carrier-Free
Yes
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy. Marieke C Verweij , Scott G Hansen , Ravi Iyer , Nessy John , Daniel Malouli, David Morrow, Isabel Scholz, Jennie Womack, Shaheed Abdulhaqq, Roxanne M Gilbride, Colette M Hughes, Abigail B Ventura, Julia C Ford, Andrea N Selseth, Kelli Oswald, Rebecca Shoemaker, Brian Berkemeier, William J Bosche, Michael Hull, Jason Shao, Jonah B Sacha, Michael K Axthelm, Paul T Edlefsen, Jeffrey D Lifson, Louis J Picker, Klaus Früh. Science (New York, N.Y.). 2021 April;372:eabe9233. PubMed: 33766941 PMC: PMC8354429

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.